In this video, I go through Sangamo’s updated data with their Hemophilia A and Beta-Thalassemia treatments. I also talk about Viking Therapeutics’ VK5211, a potent selective androgen receptor modulator.
Follow me @matthewlepoire
*This is not investment advice*
http://www.breakingbiotech.com
#breakingbiotech #SGMO #VKTX
